202 related articles for article (PubMed ID: 6714917)
1. [Programmed stimulation in patients with malignant ventricular arrhythmia. II: Individual optimization of anti-arrhythmia therapy].
Senges J; Lengfelder W; Jauernig R; Brachmann J; Rizos I; Kübler W
Herz; 1984 Apr; 9(2):77-82. PubMed ID: 6714917
[TBL] [Abstract][Full Text] [Related]
2. [Programmed stimulation in patients with malignant ventricular arrhythmias. I: Diagnostic value].
Senges J; Lengfelder W; Jauernig R; Brachmann J; Rizos I; Kübler W
Herz; 1984 Feb; 9(1):45-51. PubMed ID: 6200414
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of malignant ventricular tachyarrhythmia with amiodarone: comparison of empirical administration and administration guided by Holter or ventricular stimulation. Results of the parallel test].
Raviele A; Di Pede F; Gasparini G; Zanocco A; Delise P; Bonso A; D'Este D; Piccolo E
G Ital Cardiol; 1991 Mar; 21(3):259-69. PubMed ID: 1894120
[TBL] [Abstract][Full Text] [Related]
4. Is programmed stimulation of value in predicting the long-term success of antiarrhythmic therapy for ventricular tachycardias?
Kim SG; Seiden SW; Felder SD; Waspe LE; Fisher JD
N Engl J Med; 1986 Aug; 315(6):356-62. PubMed ID: 2426592
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic factors after sustained ventricular fibrillation or tachycardia. A multivariate study apropos of 160 cases].
Fleurant E; Lacroix D; Klug D; Warembourg H; Kacet S; Lekieffre J
Arch Mal Coeur Vaiss; 1996 Apr; 89(4):435-44. PubMed ID: 8763003
[TBL] [Abstract][Full Text] [Related]
6. [Graded criteria to assess the effectiveness of anti-arrhythmia therapy in patients with ventricular tachyarrhythmia by serial electrophysiological testing].
Borggrefe M; Breithardt G
Z Kardiol; 1986 Feb; 75(2):70-9. PubMed ID: 3705680
[TBL] [Abstract][Full Text] [Related]
7. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
[TBL] [Abstract][Full Text] [Related]
8. [Ventricular tachyarrhythmia. Drug therapy and evaluation of success].
Seipel L; Kühlkamp V
Z Kardiol; 1993; 82 Suppl 5():155-61. PubMed ID: 8154157
[TBL] [Abstract][Full Text] [Related]
9. Role of nonsustained ventricular tachycardia and programmed ventricular stimulation for risk stratification in patients with idiopathic dilated cardiomyopathy.
Becker R; Haass M; Ick D; Krueger C; Bauer A; Senges-Becker JC; Voss F; Hilbel T; Niroomand F; Katus HA; Schoels W
Basic Res Cardiol; 2003 Jul; 98(4):259-66. PubMed ID: 12835955
[TBL] [Abstract][Full Text] [Related]
10. [Are anti-arrhythmia agents superior to a beta blocker in treating life-threatening ventricular arrhythmias? Preliminary results of a controlled study].
Steinbeck G; Andresen D; von Leitner ER
Z Kardiol; 1986; 75 Suppl 5():47-55. PubMed ID: 2435071
[TBL] [Abstract][Full Text] [Related]
11. [Predictive factors of induction of ventricular arrhythmia under amiodarone].
Bourret N; Kirkorian G; Chevalier P; Bellon C; Richalet C; Bouchayer D; Bonnefoy E; Touboul P
Arch Mal Coeur Vaiss; 1996 Oct; 89(10):1277-81. PubMed ID: 8952825
[TBL] [Abstract][Full Text] [Related]
12. Long-term antiarrhythmic pharmaco-therapy guided by Holter monitoring in patients with malignant ventricular arrhythmias and ischemic heart disease.
Trusz-Gluza M; Gasior Z; Wnuk-Wojnar AM; Filipecki A; Szydło K; Giec L
Mater Med Pol; 1992; 24(4):229-32. PubMed ID: 1308049
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of malignant ventricular arrhythmia guided by electrophysiologic study].
Brandão L; Carpinteiro L; Sousa J; Vagueiro MC
Acta Med Port; 1998 Jan; 11(1):9-16. PubMed ID: 9580363
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of Nifekalant hydrochloride for life-threatening ventricular tachyarrhythmias in patients with resistance to lidocaine: a study of patients with out-of-hospital cardiac arrest].
Amino M; Yoshioka K; Iwata O; Fujikura H; Deguchi Y; Ban K; Shiina Y; Goto S; Handa S; Tanabe T; Nakagawa Y; Morita S; Iwase H; Yamamoto I; Inokuchi S; Marutani Y
J Cardiol; 2003 Mar; 41(3):127-34. PubMed ID: 12674997
[TBL] [Abstract][Full Text] [Related]
15. [Determination of anti-arrhythmia therapy of ventricular arrhythmias based on programmed ventricular stimulation].
Herold M; Hrdlicka S; Osmera P; Gregor P
Vnitr Lek; 1991; 37(11-12):833-40. PubMed ID: 1796555
[TBL] [Abstract][Full Text] [Related]
16. Propafenone in the treatment of patients with malignant ventricular tachyarrhythmias.
Kowey PR; Stohler JL; Friehling TD; Marinchak RA
Can J Cardiol; 1991 May; 7(4):175-80. PubMed ID: 2070286
[TBL] [Abstract][Full Text] [Related]
17. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].
Tonet J; Hidden F; Naditch L; Coutte R; Himbert C; Frank R
Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771
[TBL] [Abstract][Full Text] [Related]
18. [Antiarrhythmia effectiveness of oral sotalol in patients with coronary heart disease and ventricular tachycardias].
Trappe HJ; Klein H; Lichtlen PR
Z Kardiol; 1987 Oct; 76(10):630-4. PubMed ID: 3687165
[TBL] [Abstract][Full Text] [Related]
19. [Importance of programmed ventricular stimulation in the evaluation of proarrhythmic effects of orally administered anti-arrhythmia agents].
Pleskot M; Pidrman V; Tilser P; Parízek P
Vnitr Lek; 1995 Sep; 41(9):581-5. PubMed ID: 7483346
[TBL] [Abstract][Full Text] [Related]
20. Use of Holter functions of the implantable pacemaker to control antiarrhythmic therapy of supraventricular and ventricular recurrent tachycardias.
Lukl J
Cor Vasa; 1988; 30(6):413-22. PubMed ID: 3234007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
